Virtu KCG Holdings’s VanEck Pharmaceutical ETF PPH Stock Holding History

Virtu KCG Holdings’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$969K	Buy	+16,401	New	+$928K	0.03%	597
2016 Q4	–	Sell	-6,548	Closed	-$376K	–	3709
2016 Q3	$376K	Buy	+6,548	New	+$393K	0.01%	1682
2016 Q2	–	Sell	-12,337	Closed	-$709K	–	3255
2016 Q1	$709K	Buy	+12,337	New	+$730K	0.02%	866
2015 Q4	–	Sell	-7,179	Closed	-$452K	–	3846
2015 Q3	$452K	Buy	+7,179	New	+$505K	0.01%	1639
2015 Q1	–	Sell	-4,200	Closed	-$270K	–	3712
2014 Q4	$270K	Buy	+4,200	New	+$268K	﹤0.01%	2475
2014 Q3	–	Sell	-11,795	Closed	-$732K	–	3949
2014 Q2	$732K	Buy	11,795 +5,767	+96%	+$343K	0.01%	1508
2014 Q1	$352K	Buy	6,028 +178	+3%	+$10.1K	﹤0.01%	2342
2013 Q4	$311K	Buy	+5,850	New	+$296K	﹤0.01%	2546

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

SCM

Stuyvesant Capital Management Armonk, New York $41.1M AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Virtu KCG Holdings's PPH Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2017: 16,401 shares worth $969K. The stake represents 0.03% of the portfolio and ranks #597 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in PPH as recently as Q3 2016.

Virtu KCG Holdings first reported a position in PPH in Q4 2013 and has held it in 8 quarters since. 50 funds tracked by Wall St. Rank hold PPH as of Q2 2017.

Virtu KCG Holdings held 16,401 shares of VanEck Pharmaceutical ETF worth $969K as of Q2 2017.
VanEck Pharmaceutical ETF was a new Virtu KCG Holdings position in Q2 2017.
VanEck Pharmaceutical ETF made up 0.03% of Virtu KCG Holdings's portfolio in Q2 2017, its #597 holding.
Virtu KCG Holdings first reported a position in VanEck Pharmaceutical ETF in Q4 2013 and has held it in 8 quarters since.
50 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.